Expressions of CD8+TILs, PD-L1 and Foxp3+TILs in stage I NSCLC guiding adjuvant chemotherapy decisions

PURPOSE: Currently, adjuvant chemotherapy is recommended for patients with high risk stage I non-small cell lung cancer (NSCLC). However, identifying high risk patients remains a challenge. This study aims to identify the patient cohorts more likely to benefit from adjuvant chemotherapy based on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Feifei, Meng, Xiangjiao, Wang, Xin, Yuan, Jupeng, Liu, Sujing, Mu, Dianbin, Zhu, Hui, Kong, Li, Yu, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325445/
https://www.ncbi.nlm.nih.gov/pubmed/27602763
http://dx.doi.org/10.18632/oncotarget.11793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325445/
https://www.ncbi.nlm.nih.gov/pubmed/27602763
http://dx.doi.org/10.18632/oncotarget.11793

Ejemplares similares